Back to series
Efficacy and Safety of Aficamten in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ahmad Masri
Sign up and create your MedShr account in order to start this learning module
MedShr

Efficacy and Safety of Aficamten in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Ahmad Masri
Expected time taken: 20 mins

Late Breaking Clinical Trial - Presented at #ESC HF 2022

Sign up to start learning
,